Stockadora

8-K filings / November 16, 2026

REGENEREX PHARMA, INC.: A change of auditor

REGENEREX PHARMA, INC. filed a current report (Form 8-K) with the SEC on November 16, 2026. It reports a change of auditor.

Item 4.01

Change of auditor

  • New auditor Rosenfield and Company PLLC From the filing
    Source
    “On October 28, 2026, the Company’s Board of Directors finalized the approval of the appointment of Rosenfield and Company PLLC CPA of Corinth, Texas, as the Company’s independent registered public accounting firm, as per the engagement letter effective October 26, 2026.”
    Read by code from this sentence of the filing.
  • Engaged on October 28, 2026 From the filing
    Source
    “On October 28, 2026, the Company’s Board of Directors finalized the approval of the appointment of Rosenfield and Company PLLC CPA of Corinth, Texas, as the Company’s independent registered public accounting firm, as per the engagement letter effective October 26, 2026.”
    Read by code from this sentence of the filing.
Not investment advice.Read the filing on SEC.gov

Facts read from the filing's own text; a fact the filing does not state clearly is left out. All documents of this filing on SEC.gov.